BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37620828)

  • 1. Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG.
    Giacobbe DR; Dettori S; Di Pilato V; Asperges E; Ball L; Berti E; Blennow O; Bruzzone B; Calvet L; Capra Marzani F; Casabella A; Choudaly S; Dartevel A; De Pascale G; Di Meco G; Fallon M; Galerneau LM; Gallego M; Giacomini M; González Sáez A; Hänsel L; Icardi G; Koehler P; Lagrou K; Lahmer T; Lewis White P; Magnasco L; Marchese A; Marelli C; Marín-Arriaza M; Martin-Loeches I; Mekontso-Dessap A; Mikulska M; Mularoni A; Nordlander A; Poissy J; Russelli G; Signori A; Tascini C; Vaconsin LM; Vargas J; Vena A; Wauters J; Pelosi P; Timsit JF; Bassetti M; ;
    Crit Care; 2023 Aug; 27(1):323. PubMed ID: 37620828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative serum (1,3) -β-D-glucan has a low power to exclude Pneumocystis jirovecii pneumonia (PJP) in HIV-uninfected patients with positive qPCR.
    Huang Y; Yi J; Song JJ; Du LJ; Li XM; Cheng LL; Yan SX; Li HL; Liu YM; Zhan HT; Dou YL; Li YZ
    Ann Clin Microbiol Antimicrob; 2023 Nov; 22(1):102. PubMed ID: 37986091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of serum (1-3)-β-D-glucan for Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis.
    Del Corpo O; Butler-Laporte G; Sheppard DC; Cheng MP; McDonald EG; Lee TC
    Clin Microbiol Infect; 2020 Sep; 26(9):1137-1143. PubMed ID: 32479781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a Turbidimetric β-d-Glucan Test for Detection of Pneumocystis jirovecii Pneumonia.
    Dichtl K; Seybold U; Wagener J
    J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29720434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumocystis jirovecii pneumonia in AIDS and non-AIDS immunocompromised patients - an update.
    Lee YT; Chuang ML
    J Infect Dev Ctries; 2018 Oct; 12(10):824-834. PubMed ID: 32004150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Performance of BAL Metagenomic Next-Generation Sequence and Serum (1,3)-β-D-Glucan for Differential Diagnosis of
    Liu L; Yuan M; Shi Y; Su X
    Front Cell Infect Microbiol; 2021; 11():784236. PubMed ID: 35004353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumocystis jirovecii pneumonia: a case report.
    Gri J; Jain V
    J Med Case Rep; 2024 Feb; 18(1):52. PubMed ID: 38342895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pneumocystis jirovecii and quantitative PCR: Pneumonia or colonization?].
    Gazaignes S; Bergeron A; Menotti J; Desseaux K; Molina JM; De Castro N
    Rev Mal Respir; 2020 Apr; 37(4):299-307. PubMed ID: 32273116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum (1,3)-Beta-d-Glucan has suboptimal performance for the diagnosis of Pneumocystis jirovecii pneumonia in cancer patients and correlates poorly with respiratory burden as measured by quantitative PCR.
    Szvalb AD; Malek AE; Jiang Y; Bhatti MM; Wurster S; Kontoyiannis DP
    J Infect; 2020 Sep; 81(3):443-451. PubMed ID: 32650108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of ß-d-Glucan Assay for the First-Line Diagnosis of
    Bigot J; Vellaissamy S; Senghor Y; Hennequin C; Guitard J
    J Fungi (Basel); 2022 Jun; 8(7):. PubMed ID: 35887420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome and prognostic factors of Pneumocystis jirovecii pneumonia in immunocompromised adults: a prospective observational study.
    Gaborit BJ; Tessoulin B; Lavergne RA; Morio F; Sagan C; Canet E; Lecomte R; Leturnier P; Deschanvres C; Khatchatourian L; Asseray N; Garret C; Vourch M; Marest D; Raffi F; Boutoille D; Reignier J
    Ann Intensive Care; 2019 Nov; 9(1):131. PubMed ID: 31776705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Point-Counterpoint: Should Serum β-d-Glucan Testing Be Used for the Diagnosis of Pneumocystis jirovecii Pneumonia?
    Corsi-Vasquez G; Ostrosky-Zeichner L; Pilkington EF; Sax PE
    J Clin Microbiol; 2019 Dec; 58(1):. PubMed ID: 31434728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population.
    Avino LJ; Naylor SM; Roecker AM
    Ann Pharmacother; 2016 Aug; 50(8):673-9. PubMed ID: 27242349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Veno-Venous Extracorporeal Membrane Oxygenation for Severe Pneumocystis jirovecii Pneumonia in an Immunocompromised Patient without HIV Infection.
    Nureki SI; Usagawa Y; Watanabe E; Takenaka R; Shigemitsu O; Abe T; Yasuda N; Goto K; Kitano T; Kadota JI
    Tohoku J Exp Med; 2020 Apr; 250(4):215-221. PubMed ID: 32249237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of metagenomic next-generation sequencing in the diagnosis and treatment guidance of Pneumocystis jirovecii pneumonia in renal transplant recipients.
    Zhang F; Chen J; Huang H; Deng X; Zhang W; Zeng M; Liu R; Dai L; Wan Q
    Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1933-1942. PubMed ID: 33880744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors associated with Pneumocystis jirovecii pneumonia in non-HIV immunocompromised patients and co-pathogens analysis by metagenomic next-generation sequencing.
    Huang L; Xu S; Huang Z; Chen Y; Xu N; Xie B
    BMC Pulm Med; 2023 Feb; 23(1):72. PubMed ID: 36829171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Host factors and characteristics of hospitalized patients with pneumocystis jirovecii pneumonia].
    Chen RX; Sun YX; Liu XN; Shao C; Huang H; Hu K; Xu J; Li J; Yi X; Zhang ZJ; Xu Z
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Sep; 45(9):881-887. PubMed ID: 36097925
    [No Abstract]   [Full Text] [Related]  

  • 18. High initial (1, 3) Beta-d-Glucan concentration may be a predictor of satisfactory response of c aspofungin combined with TMP/SMZ for HIV-negative patients with moderate to severe Pneumocystis jirovecii pneumonia.
    Jin F; Liu XH; Chen WC; Fan ZL; Wang HL
    Int J Infect Dis; 2019 Nov; 88():141-148. PubMed ID: 31442630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of 1,3 Beta-D-Glucan Detection in non-HIV Immunocompromised Mechanical Ventilated Critically Ill Patients with ARDS and Suspected Pneumocystis jirovecii Pneumonia.
    Lahmer T; da Costa CP; Held J; Rasch S; Ehmer U; Schmid RM; Huber W
    Mycopathologia; 2017 Aug; 182(7-8):701-708. PubMed ID: 28378239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Multivariable Prediction Model for Pneumocystis jirovecii Pneumonia in Hematology Patients with Acute Respiratory Failure.
    Azoulay E; Roux A; Vincent F; Kouatchet A; Argaud L; Rabbat A; Mayaux J; Perez P; Pène F; Nyunga M; Bruneel F; Klouche K; Mokart D; Darmon M; Chevret S; Lemiale V
    Am J Respir Crit Care Med; 2018 Dec; 198(12):1519-1526. PubMed ID: 29995433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.